Last reviewed · How we verify

NCT05672784

Genicular Nerve Block Versus Its Combination With Infiltration Between Popliteal Artery and Capsule of Posterior Knee

Recruiting now NA Last updated 26 November 2024
What this trial tests

NA trial testing GNB plus standard analgesia in Postoperative Pain in 63 participants. Currently enrolling.

Timeline
5 November 2022
Primary endpoint
5 December 2024
30 December 2024

Quick facts

Lead sponsorZagazig University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment63
Start date5 November 2022
Primary completion5 December 2024
Estimated completion30 December 2024
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Zagazig University

Who can join

Adults 21 to 60, any sex, with Postoperative Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Comparison of the analgesic and physical recovery effect of genicular nerve block (GNB) alone and (GNB + infiltration between popliteal artery and posterior capsule of the knee (IPACK) in patients undergoing total knee replacement

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Comparison of genicular nerve block and its combination with IPACK block for analgesia and recovery after total knee arthroplasty: a randomized trial.
    Fathi HM, Fahmy AM, Shaker MA, Kamel AAF. · · 2025 · PMID 41318369 · DOI 10.1186/s12871-025-03408-0

Verify or expand the search:

Other recruiting trials for Postoperative Pain

Currently open trials in the same condition.

Other Zagazig University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05672784.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing